Nanoparticles enter cells through active processes, thanks to their capability of interacting with the cellular machinery. The protein layer (corona) that forms on their surface once nanoparticles are in contact with biological fluids, such as the cell serum, mediates the interactions with cells <i>in situ</i>. As a consequence of this, here we show that the same nanomaterial can lead to very different biological outcomes, when exposed to cells in the presence or absence of a preformed corona. In particular, silica nanoparticles exposed to cells in the absence of serum have a stronger adhesion to the cell membrane and higher internalization efficiency, in comparison to what is observed in medium containing serum, when a preformed corona is ...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...
Nanoparticles have unique capacities of interacting with the cellular machinery and entering cells. ...
Nanoparticles have unique capacities of interacting with the cellular machinery and entering cells. ...
Nanoparticles have unique capacities of interacting with the cellular machinery and entering cells. ...
Nanoparticles have unique capacities of interacting with the cellular machinery and entering cells. ...
Nanoparticles have unique capacities of interacting with the cellular machinery and entering cells. ...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nanoparticles enter cells through active processes, thanks to their capability of interacting with t...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...
Nanoparticles have unique capacities of interacting with the cellular machinery and entering cells. ...
Nanoparticles have unique capacities of interacting with the cellular machinery and entering cells. ...
Nanoparticles have unique capacities of interacting with the cellular machinery and entering cells. ...
Nanoparticles have unique capacities of interacting with the cellular machinery and entering cells. ...
Nanoparticles have unique capacities of interacting with the cellular machinery and entering cells. ...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...
Nano-sized objects, such as nanoparticles and other drug carriers used in nanomedicine, once in cont...